Keywords: Watson Pharma, Xopenox HFA, Bronchospasm, Epiduo Gel, Acne, Sunovion, Dainippon Sumitomo, Galderma, ANDAs, Law suits, USA

Watson confirms patent challenges for Xopenox HFA and Epiduo Gel

Article | 31 July 2012

US generics drugmaker Watson Pharmaceuticals NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories filed an Abbreviated New Drug Application) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in